Sustained responses after clofarabine-based sequential allogeneic stem cell transplantation in children with high-risk, relapse and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: a study on behalf of the French society of bone marrow transplantation or cell therapy (SFGM-TC)

Leuk Lymphoma. 2016 Dec;57(12):2937-2941. doi: 10.1080/10428194.2016.1177721. Epub 2016 May 17.

Authors

Audrey Grain¹, Anne Sirvent², Marion Strullu¹, Mechinaud Françoise³, Mohamad Mohty⁴, Thierry Guillaume⁵, Patrice Chevallier⁵, Fanny Rialland¹

Affiliations

¹ a Department of Paediatric Haematology , CHU de Nantes , Nantes , France.
² b Department of Paediatric Haematology , CHU de Montpellier , Montpellier , France.
³ c Department of Paediatric Haematology , Melbourne , Australia.
⁴ d Hematology Department , Saint Louis Hospital, APHP , Paris , France.
⁵ e Haematology Department , CHU Nantes , Nantes , France.

PMID: 27184944
DOI: 10.1080/10428194.2016.1177721

No abstract available

Publication types

Letter

MeSH terms

Adenine Nucleotides / therapeutic use*
Adolescent
Arabinonucleosides / therapeutic use*
Child
Child, Preschool
Clofarabine
Combined Modality Therapy
Female
France
Hematopoietic Stem Cell Transplantation / methods*
Hematopoietic Stem Cell Transplantation / standards
Humans
Leukemia, Myeloid, Acute / mortality
Leukemia, Myeloid, Acute / therapy*
Leukemia, Myelomonocytic, Juvenile / mortality
Leukemia, Myelomonocytic, Juvenile / therapy*
Male
Recurrence
Retrospective Studies
Risk Factors
Transplantation, Homologous
Treatment Outcome
Young Adult

Substances

Adenine Nucleotides
Arabinonucleosides
Clofarabine